Log In
Print
BCIQ
Print
Print this Print this
 

Vascepa, icosapent ethyl (formerly AMR101, Miraxion)

Also known as: AMR-101, LAX-101

  Manage Alerts
Collapse Summary General Information
Company Amarin Corp. plc
Description>96% pure ethyl ester of eicosapentaenoic acid (ethyl-EPA)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$169.0M

$15.0M

$154.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today